Skip to main content
. 2024 Dec 30;25:1255. doi: 10.1186/s12864-024-11165-6

Table 2.

The top 20 genes from gene-based analysis by using VEGAS2 tool

Chr Gene Number
of SNPs
Start position Stop position P-value Top-SNP Top-SNP P-value
FEV1
12 TESC 185 117,476,727 117,537,251 6.40E-05 rs7304889 3.75E-05
12 KRT5 28 52,908,358 52,914,243 1.35E-04 rs60314569 4.96E-05
17 ARHGDIA 5 79,825,596 79,829,282 1.57E-04 rs113301975 1.49E-04
23 MBNL3 43 131,503,342 131,623,996 1.71E-04 rs1952453 1.38E-04
6 GPR126 172 142,623,055 142,767,403 1.75E-04 rs2039986 1.60E-05
23 RAP2C 5 131,337,051 131,353,508 1.95E-04 rs5977658 2.00E-04
23 RAP2C-AS1 116 131,352,534 131,566,839 2.05E-04 rs1952453 1.38E-04
17 TBC1D16 279 77,906,141 78,009,657 2.23E-04 rs11653700 2.39E-06
17 FAM195B 18 79,780,236 79,791,170 3.41E-04 rs140438341 1.96E-04
6 FHL5 103 97,010,423 97,064,512 3.50E-04 rs12204342 2.56E-05
7 ADCYAP1R1 133 31,092,075 31,151,093 4.12E-04 rs4723047 8.25E-08
17 PPP1R27 2 79,791,367 79,792,926 4.25E-04 rs34856581 3.43E-04
7 SEPT7P2 79 45,763,385 45,808,617 4.54E-04 rs1004028 3.60E-04
10 FAM196A 106 128,933,689 128,994,422 5.58E-04 rs2486971 9.90E-05
17 P4HB 34 79,801,033 79,818,544 5.91E-04 rs111839893 2.94E-04
23 FRMD7 32 131,211,020 131,262,050 7.96E-04 rs5933079 5.97E-05
12 C12orf80 5 52,599,364 52,604,639 8.36E-04 rs4144987 3.06E-03
23 TAF7L 39 100,523,240 100,548,059 9.90E-04 rs5991927 3.01E-04
12 IRAK4 53 44,152,746 44,183,346 1.02E-03 rs4251463 3.90E-04
11 LOC440040 506 49,580,079 49,831,969 1.02E-03 rs11040429 1.72E-04
FVC
6 GPR126 172 142,623,055 142,767,403 1.50E-05 rs9403380 1.27E-07
6 FKBP5 225 35,541,361 35,696,360 1.80E-05 rs12153967 4.39E-06
13 SLC15A1 173 99,336,054 99,404,929 2.40E-05 rs1768042 2.97E-04
18 AQP4 17 24,432,007 24,445,716 2.60E-05 rs455671 5.10E-05
9 SETX 324 135,136,826 135,230,372 1.78E-04 rs508021 1.22E-04
12 C12orf80 5 52,599,364 52,604,639 2.67E-04 rs1317997 9.70E-04
12 IRAK4 53 44,152,746 44,183,346 3.45E-04 rs4251463 1.55E-04
11 LOC646813 36 50,368,317 50,379,802 3.57E-04 rs692671 2.69E-04
11 LOC440040 506 49,580,079 49,831,969 3.62E-04 rs10742953 9.12E-05
19 CABP5 83 48,532,639 48,547,311 3.82E-04 rs111784716 2.17E-04
23 RAP2C 5 131,337,051 131,353,508 3.85E-04 rs5977658 3.52E-04
7 ADCYAP1R1 133 31,092,075 31,151,093 3.91E-04 rs4503014 1.48E-07
23 RAP2C-AS1 116 131,352,534 131,566,839 4.08E-04 rs142507995 3.36E-04
7 DNAJB6 283 157,129,709 157,210,133 4.26E-04 rs12154512 3.07E-04
16 CALB2 88 71,392,615 71,424,342 4.86E-04 rs11545954 1.40E-05
23 MBNL3 43 131,503,342 131,623,996 6.17E-04 rs5977691 3.36E-04
10 FGF8 2 103,529,886 103,540,126 6.74E-04 rs1348870 1.57E-04
23 FRMD7 32 131,211,020 131,262,050 6.84E-04 rs5933079 1.03E-04
12 MKRN9P 5 88,176,662 88,178,488 7.17E-04 rs1675574 4.63E-04
19 SLC5A5 32 17,982,781 18,005,983 7.43E-04 rs7255433 7.70E-05
FEV1/FVC
5 RPL37 9 40,831,429 40,835,387 2.43E-04 rs2291782 8.52E-04
2 LOC101928113 6 86,116,402 86,119,375 3.86E-04 rs4313976 1.21E-04
2 LOC728730 234 39,664,556 39,828,484 6.32E-04 rs10210842 3.22E-05
1 KLHL17 25 895,966 901,099 7.10E-04 rs41285808 6.56E-05
1 CD1B 4 158,297,739 158,301,321 1.36E-03 rs962879 8.61E-04
2 C2orf81 4 74,641,302 74,644,844 1.42E-03 rs7571984 9.31E-04
3 GSK3B 263 119,540,801 119,813,264 1.52E-03 rs60235167 1.30E-04
3 BTD 77 15,642,858 15,687,328 1.59E-03 rs2455822 2.22E-04
1 C8A 153 57,320,442 57,383,894 1.77E-03 rs2284952 1.16E-03
2 GAL3ST2 62 242,716,239 242,743,702 2.01E-03 rs74704923 5.61E-04
3 BPESC1 39 138,823,026 138,844,005 2.05E-03 rs586043 1.38E-03
2 MDH1 6 63,815,742 63,834,330 2.09E-03 rs17618390 6.18E-04
4 CCDC110 76 186,366,337 186,392,913 2.19E-03 rs57923780 5.62E-06
5 GCNT4 7 74,323,288 74,326,724 2.25E-03 rs3811986 1.78E-03
3 LINC00606 11 10,801,168 10,805,877 2.41E-03 rs35131573 6.57E-04
3 RAD18 281 8,918,879 9,005,159 2.67E-03 rs579898 8.73E-04
3 Section 62 56 169,684,579 169,716,161 2.89E-03 rs3348 3.65E-04
1 HNRNPU 2 245,013,601 245,027,827 2.93E-03 rs3766527 7.68E-03
3 RNF168 48 196,195,656 196,230,639 3.20E-03 rs9869437 7.07E-04
3 DCBLD2 227 98,514,813 98,620,533 3.29E-03 rs2439237 7.02E-04

The content discussed in detail was bold